Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 3 results for author "Hunan Julhakyan".

Back to authors

Thumbnail for Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

ABCL - 1390

Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PMBCL)

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol

CLL - 1376

Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

HL - 1412

PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.